Loading…
Loading…
WGRX (Wellgistics Health, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
WGRX does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for WGRX and 80,000+ other tickers.
See exactly how WGRX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for WGRX and 80,000+ other tickers.
Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers…
Trading under new symbol (NASDAQ: MEDS) completes corporate rebranding from prior corporate name Wellgistics Health (NASDAQ: WGRX) TAMPA, FL / ACCESS Newswire / July 22, 2026 / DataMEDS AI, Inc., (NASDAQ:MEDS, "DataMEDS," or the "Company"), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to provide integrated solutions for the generation, rationalization, intervention, transaction and monetization of health data, today announced that it has officially completed its stock trading symbol change to ‘MEDS'. The Company began trading under the new stock symbol ‘MEDS' on the NASDAQ Capital Market stock exchange effective at the start of trading on Wednesday, July 22, 2026.
Leading Health IT Company's Rebranding Reflects Updated Healthcare Ecosystem Aligned with AI Integration to Optimize Patient Control of Healthcare Data TAMPA, Fla., July 21, 2026 /PRNewswire/ -- Wellgistics Health, Inc., (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it has officially completed its name change to DataMEDS AI, Inc. ("DataMEDS" or "the Company").
TAMPA, FL / ACCESS Newswire / July 20, 2026 / Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader implementing EinsteinRx™ artificial intelligence prescription drug routing into blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey, today announced an updated record date for the distribution of the Dream Bowl 2026 Meme Coin (https://www.biconomy.com/exchange/DREAM1_USDT) to Wellgistics stockholders. On December 3, 2025, Wellgistics announced that it would distribute one (1) Dream Bowl 2026 Meme Coin for every one (1) share of Wellgistics Health common stock held as of a designated record date.
Rubenstein PR named AOR for Wellgistics Health (WGRX) to launch its AI Healthcare ecosystem, expanding EinsteinRx & PharmacyChain for advanced Health IT.
Experienced Healthcare Information Technology Specialist Joins Leading Pharmaceutical IT Company TAMPA, FL / ACCESS Newswire / July 15, 2026 / Wellgistics Health, Inc. (the "Company" or "Wellgistics") (NASDAQ:WGRX), a Health IT leader, integrating pharmacy dispensing AI platform EinsteinRx™ into patented pharmacy smart contracts platform PharmacyChain™, today announced that it appointed healthcare information technology executive Brett Thompson as the Company's consulting Chief Technology Officer (CTO). Mr. Thompson has more than thirty years of experience designing, developing, and leading enterprise software solutions, including more than seventeen years focused on healthcare and pharmacy technology.